Politics collide with science ahead of new ACIP meetingnews2025-06-23T20:26:17+00:00June 23rd, 2025|Endpoints News|
Amgen plans more gradual MariTide dosing in Phase 3 news2025-06-23T20:25:37+00:00June 23rd, 2025|Endpoints News|
FDA approves AstraZeneca, Daiichi Sankyo’s Datroway in EGFR-mutated lung cancernews2025-06-23T20:03:02+00:00June 23rd, 2025|Endpoints News|
Roche plans to pit next-gen hemophilia A antibody against Hemlibra in Phase 3news2025-06-23T19:33:19+00:00June 23rd, 2025|Endpoints News|
Supreme Court asks DOJ to weigh in on Hikma ‘skinny label’ fightnews2025-06-23T15:53:44+00:00June 23rd, 2025|Endpoints News|
Exelixis’ positive Phase 3 colorectal cancer data boost stocknews2025-06-23T15:27:00+00:00June 23rd, 2025|Endpoints News|
Novo Nordisk ends partnership with Hims over compounded drugsnews2025-06-23T15:23:23+00:00June 23rd, 2025|Endpoints News|
Formation Bio’s up to €545M licensing deal with Sanofi; Otsuka, Harbour BioMed team upnews2025-06-23T15:15:50+00:00June 23rd, 2025|Endpoints News|
Cidara’s preventive influenza biologic is effective in Phase 2b trialnews2025-06-23T14:38:50+00:00June 23rd, 2025|Endpoints News|
